STOCK TITAN

BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy market, will release its second quarter 2025 financial results after market close on Thursday, August 7, 2025.

The company will host a conference call and webcast at 4:30 PM ET where management will discuss financial results and provide a business update. Investors can access the webcast through BioLife's website or join via phone using the provided toll-free numbers.

BioLife Solutions (NASDAQ: BLFS), uno dei principali sviluppatori e fornitori di prodotti e servizi per la bioproduzione nel mercato della terapia cellulare e genica, pubblicherà i suoi risultati finanziari del secondo trimestre 2025 dopo la chiusura del mercato di giovedì 7 agosto 2025.

L'azienda terrà una conference call e una webcast alle 16:30 ET durante le quali il management discuterà i risultati finanziari e fornirà un aggiornamento sul business. Gli investitori potranno accedere alla webcast tramite il sito web di BioLife o partecipare telefonicamente utilizzando i numeri verdi forniti.

BioLife Solutions (NASDAQ: BLFS), un destacado desarrollador y proveedor de productos y servicios de bioproducción para el mercado de terapia celular y génica, publicará sus resultados financieros del segundo trimestre de 2025 después del cierre del mercado el jueves 7 de agosto de 2025.

La compañía realizará una llamada conferencia y una transmisión en vivo a las 4:30 PM ET donde la dirección discutirá los resultados financieros y ofrecerá una actualización del negocio. Los inversores podrán acceder a la transmisión a través del sitio web de BioLife o unirse por teléfono utilizando los números gratuitos proporcionados.

BioLife Solutions (NASDAQ: BLFS)는 세포 및 유전자 치료 시장을 위한 생물생산 제품과 서비스를 선도적으로 개발 및 공급하는 기업으로, 2025년 2분기 재무 결과2025년 8월 7일 목요일 장 마감 후에 발표할 예정입니다.

회사는 동부 시간 오후 4시 30분에 컨퍼런스 콜과 웹캐스트를 진행하며, 경영진이 재무 결과를 논의하고 사업 현황을 업데이트할 예정입니다. 투자자들은 BioLife 웹사이트를 통해 웹캐스트에 접속하거나 제공된 무료 전화번호를 이용해 참여할 수 있습니다.

BioLife Solutions (NASDAQ : BLFS), un développeur et fournisseur de premier plan de produits et services de bioproduction pour le marché des thérapies cellulaires et géniques, publiera ses résultats financiers du deuxième trimestre 2025 après la clôture du marché le jeudi 7 août 2025.

La société organisera une conférence téléphonique et une webdiffusion à 16h30 ET où la direction discutera des résultats financiers et fournira une mise à jour commerciale. Les investisseurs pourront accéder à la webdiffusion via le site web de BioLife ou rejoindre par téléphone en utilisant les numéros gratuits fournis.

BioLife Solutions (NASDAQ: BLFS), ein führender Entwickler und Anbieter von Bioproduktionsprodukten und -dienstleistungen für den Zell- und Gentherapiemarkt, wird seine Finanzergebnisse für das zweite Quartal 2025 nach Börsenschluss am Donnerstag, den 7. August 2025 veröffentlichen.

Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz und Webcast veranstalten, bei der das Management die Finanzergebnisse besprechen und ein Geschäftsupdate geben wird. Investoren können den Webcast über die Website von BioLife verfolgen oder telefonisch über die bereitgestellten gebührenfreien Nummern teilnehmen.

Positive
  • None.
Negative
  • None.

BOTHELL, Wash., July 24, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's second quarter 2025 financial results will be released after market close on Thursday, August 7, 2025. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers.  A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com/ for 90 days. 

About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-second-quarter-2025-financial-results-and-business-update-on-august-7-2025-302513514.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions (BLFS) report Q2 2025 earnings?

BioLife Solutions will report Q2 2025 earnings after market close on Thursday, August 7, 2025.

How can I listen to BioLife Solutions' Q2 2025 earnings call?

You can access the webcast on BioLife's website or dial 1-833-630-0431 (US toll-free) or 1-412-317-1808 (international) at 4:30 PM ET on August 7, 2025.

What time is BioLife Solutions' Q2 2025 earnings call?

The earnings call and webcast will take place at 4:30 PM ET (1:30 PM PT) on August 7, 2025.

How long will BioLife Solutions' Q2 2025 earnings webcast be available?

The webcast replay will be available approximately two hours after the call and will be archived on the investor relations website for 90 days.
Biolife Solutions Inc

NASDAQ:BLFS

BLFS Rankings

BLFS Latest News

BLFS Latest SEC Filings

BLFS Stock Data

1.08B
46.77M
1.85%
101.8%
7.24%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
BOTHELL